VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
OSG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
OSGOctave Specialty Group, Inc.
$4.99$225M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksOSGBalance Sheet

Octave Specialty Group, Inc. (OSG) Balance Sheet

30Y historyFree accessUpdated daily

The company's capital position has faced significant pressure, with total assets contracting from $9.3 billion in 2024Q3 to $2.1 billion in 2025Q3, signaling substantial structural downsizing.

Income StatementBalance SheetCash FlowRatios

OSG Balance Sheet

Annual statement

OSG Balance Sheet

Octave Specialty Group, Inc. (OSG) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets307.87M1.08B898.99M02.6B4.32B05.74B6.11B1.18B521.81M261.53B433.97B348.49M705.5M799.07M718.29M1.08B1.56B1B343.63M500.33M71.41M282.29M433.52M506.86M308.63M1.01B970.78M439.04M172.01M
Cash & Short-Term Investments295.75M337.18M331.9M354.96M1.93B1.85B2.83B3.25B493.42M1.18B521.81M5.31B5.16B6.23B6.11B799.07M718.29M1.08B1.56B1B343.63M500.33M541.18M274.83M421.58M491.58M298.95M234.48M127.77M145.53M120.25M
Cash Only79.1M68.44M47.27M19.22M30M17M20M24M63.09M623.7M91.03M35.74M73.9M77.37M43.84M16M9.5M113.23M107.81M123.93M31.87M28.3M19.96M24.45M25.82M76.58M45.43M13.59M8.24M9.26M7.73M
Short-Term Investments216.65M268.74M284.62M335.73M1.9B1.83B2.81B3.23B3.55B5.21B5.99B5.27B5.09B6.16B6.06B783.07M708.8M962.01M1.45B879.07M311.76M472.03M521.23M250.38M395.76M415M253.52M220.9M119.53M136.28M112.51M
Accounts Receivable195.17M597.73M418.79M220.31M655M2.47B2.56B2.47B2.5B1.28B1.38B--------------------
Days Sales Outstanding582.58868.43648.21644.714.46K3.65K5.99K1.82K1.79K759.331K--------------------
Inventory0000-1.76B-3.21B0-4.02B000251.33B0000000000000000000
Days Inventory Outstanding-------------------------------
Other Current Assets-331.29M00-685.67M1.65B3.12B-5.46B3.95B3.12B-1.28B-1.38B00000000000000000000
Total Non-Current Assets981.75M1.14B7.16B04.32B5.7B06.78B7B846.97M962.08M1.21T1.93T2.11B8.33B6.88B8.76B9.23B10.28B18.38B263.48M257.99M14.68M13.77B12.54B10.29B8.32B8.96B8.74B6.91B5.2B
Property, Plant & Equipment0018.11M021M23M25M25M6.79B-285.09M-523.66M-631.34M0000000000000000000
Fixed Asset Turnover--13.02x-2.55x10.74x6.24x19.84x0.07x----------------------
Goodwill534.3M540.35M418.23M69.69M61M46M46M00000514.51M514.51M00000000000000000
Intangible Assets447.45M484.73M344.77M61.4M326M362M409M427M718.93M846.97M962.08M1.21B1.41B1.67B199.16M0000000000000000
Long-Term Investments103.26M24.97M28.29M03.93B5.6B06.35B0007.86B7.83B8.63B8.33B6.88B8.76B9.23B10.28B18.38B17.42B15.97B14.76B13.77B12.54B10.29B8.32B8.96B8.74B6.91B5.2B
Other Non-Current Assets-25.02M92M6.35B-131.1M-4.32B-6.01B-480M-176M-718.93M00--------------------
Total Assets2.28B2.22B8.06B8.43B7.97B12.3B13.22B13.32B14.59B23.19B22.64B23.73B25.16B27.11B27.01B27.11B29.05B18.89B16.95B23.57B20.27B19.73B18.59B16.75B15.36B12.27B10.12B11.35B11.21B8.25B5.88B
Asset Turnover0.14x0.11x0.03x0.01x0.01x0.02x0.01x0.04x0.03x0.03x0.02x0.03x0.02x0.03x0.03x0.01x0.01x0.21x-0.16x-0.18x0.09x0.08x0.08x0.08x0.06x0.08x0.09x0.05x0.04x0.05x0.08x
Asset Growth %-294.97%-72.41%-4.39%5.71%-35.19%-6.94%-0.75%-8.7%-37.1%2.46%--5.69%-7.18%0.37%-0.39%-6.66%53.8%11.42%-28.07%16.27%2.75%6.13%10.97%9.06%25.17%21.22%-10.8%1.18%35.91%40.4%10.67%
Total Current Liabilities982.39M909.84M205.56M039M33M029M32.91M37.88M42.53M53.49M60.44M85.42M94.53M117.22M141.45M293.92M25.85M97.83M49.92M16.73M7.1B7.09B7.38B8.74B7.1B8.9B8.69B6.2B4.04B
Accounts Payable93.35M80.56M53M29.67M39M33M27M29M33M37.88M42.53M53.49M60.44M70.96M94.53M117.22M141.45M293.92M25.85M33.08M116.06M35.39M18.25M18.21M95.08M73.06M14.83M268.7M262.42M75.17M57.69M
Days Payables Outstanding594.67623.07141.04141.11486.72-167.2943.8814.23-54.0126.95-1.35K--------------------
Short-Term Debt00150M000000000000000008.36B7.25B7.08B7.08B7.28B5.51B4.89B6.14B5.96B4.32B0
Deferred Revenue (Current)582.99M187.18M00-631M-757M0-506M00-39.83M--------------------
Other Current Liabilities760.82M525.21M419.2M-36.6M204M181M-544M64M-377.09M-439.5M-398.37M-97.16M-66.9M-76.35M-423.78M-386.59M-229.12M-344.52M-94.66M-146.52M-8.53B-7.39B-7.17B-7.21B-7.5B-5.77B-5.02B-7.35B-7.14B-4.74B-151.03M
Current Ratio0.31x1.19x4.37x-66.69x130.97x-197.79x185.67x31.18x12.27x4889.02x7180.62x4.08x7.46x6.82x5.08x3.66x60.42x10.25x6.88x29.91x0.01x0.04x0.06x0.06x0.04x0.11x0.11x0.07x0.04x
Quick Ratio0.31x1.19x4.37x-111.90x228.30x-336.55x185.67x31.18x12.27x190.68x7180.62x4.08x7.46x6.82x5.08x3.66x60.42x10.25x6.88x29.91x0.01x0.04x0.06x0.06x0.04x0.11x0.11x0.07x0.04x
Cash Conversion Cycle-12.09------------------------------
Total Non-Current Liabilities621.59M227.31M6.66B7B6.65B6.45B12.07B7.41B2.93B21.55B20.66B1.12T971.12B963.18M150.17M223.6M208.26M4.64B1.87B21.19B14.03B14.34B2.08B962.83M802.36M619M424M424M424M224M224M
Long-Term Debt155.46M117.56M03.48B3.75B6.45B7.23B7.38B8.2B13.15B12.27B13.45B13.85B15.05B150.17M14.51B16.31B4.64B1.87B1.67B991.8M2.23B791.8M791.8M0619.32M424.06M424M423.93M223.86M223.8M
Capital Lease Obligations00000025M0000--------------------
Deferred Tax Liabilities253.49M65.22M70.14M00024M32M000--------------------
Other Non-Current Liabilities407.28M44.53M6.59B7B2.9B131M4.84B0-5.27B8.39B8.39B--------------------
Total Liabilities1.27B1.14B6.86B7B6.65B11.19B12.07B11.78B12.96B21.55B20.66B21.77B23.49B26.13B30.25B30.26B30.4B20.52B20.03B21.29B14.08B14.35B13.56B12.49B11.73B9.28B7.52B9.33B9.12B6.38B4.26B
Total Debt155.46M117.56M150M3.48B3.75B6.45B7.23B7.38B8.2B13.15B12.27B13.45B13.85B15.05B15.59B14.51B16.31B4.64B1.87B10.38B9.35B9.49B8.95B7.87B7.9B6.13B5.32B6.56B6.38B4.54B223.8M
Net Debt76.36M49.12M102.72M3.46B3.72B6.43B7.21B7.35B8.13B12.53B12.18B13.42B13.78B14.98B15.54B14.5B16.3B4.53B1.76B10.25B9.32B9.46B8.93B7.84B7.87B6.05B5.27B6.55B6.37B4.54B216.06M
Debt / Equity0.15x0.11x0.13x2.43x2.83x5.78x6.31x4.80x5.02x7.99x6.20x6.87x8.28x15.39x-----4.55x1.51x1.77x1.78x1.85x2.18x2.05x2.05x3.25x3.04x2.43x0.14x
Debt / EBITDA-5.11x----115.11x-65.86x21.46x-43.69x19.70x21.36x----6.37x--7.71x9.26x8.94x6.34x13.33x10.75x6.13x14.70x17.02x14.28x0.57x
Net Debt / EBITDA-2.51x----114.80x-65.64x21.29x-43.37x19.65x21.24x----6.22x--7.68x9.23x8.92x6.32x13.29x10.61x6.08x14.67x16.99x14.25x0.55x
Interest Coverage-5.25x-4.42x-5.38x--0.21x1.01x-0.98x0.32x2.13x-1.37x1.84x4.38x3.87x-2.28x-2.28x-14.70x-4.15x4.71x-15.49x-10.08x2.78x3.47x4.49x4.87x2.11x2.11x23.39x12.27x11.51x15.01x18.89x
Total Equity1.02B1.09B1.2B1.43B1.32B1.12B1.15B1.54B1.63B1.65B1.98B1.96B1.67B978.42M-3.25B-3.15B-1.35B-1.63B-3.08B2.28B6.18B5.37B5.02B4.25B3.63B2.98B2.6B2.02B2.1B1.87B1.62B
Equity Growth %-79.62%-9.15%-16.5%8.05%18.73%-2.7%-25.37%-5.89%-0.74%-16.82%-17%71.06%130.13%-3.09%-132.57%17.1%47%-235.2%-63.13%15.11%6.92%18.1%17.36%21.5%14.93%28.62%-3.7%11.94%15.94%15.03%
Book Value per Share22.3923.0225.4531.3728.5523.9824.8633.4535.0836.2643.2642.5735.6620.85-34.47-33.44-14.38-17.34-32.7222.1557.5149.1145.2838.9133.2727.3624.1718.8319.5617.8515.26
Total Shareholders' Equity698.75M715.79M856.91M1.36B1.25B1.04B1.08B1.48B1.59B1.38B1.71B1.68B1.4B702.98M-3.91B-3.81B-2.01B-2.29B-3.78B2.28B6.18B5.37B5.02B4.25B3.63B2.98B2.6B2.02B2.1B1.87B1.62B
Common Stock489K489K489K467K0000454K453K452K450K450K450K3.08M3.08M3.08M2.94M2.94M1.09M1.09M1.09M1.09M1.07M1.06M1.06M1.06M707K707K707K353K
Retained Earnings348.47M370.43M742.18M1.25B1.25B726M759M1.2B1.42B1.23B1.56B1.48B989.29M505.22M-6.3B-6.04B-4.04B-3.88B-3.55B2.11B5.45B4.69B4.03B3.38B2.82B2.4B2.04B1.71B1.45B1.26B1.07B
Treasury Stock-33.06M-33.47M-28.34M-16.57M-15M-3M-1M0-473K-471K-496K-118K-56K-19K-410.75M-411.42M-448.54M-560.54M-594.32M-646.79M-259.22M-247.58M00-11.88M-21.46M-18.87M-33.2M-33.1M-26.3M-15.07M
Accumulated OCI3.29M8.48M-188.44M-160.05M-253M58M79M42M-48.72M-52.24M-38.99M15.21M220.28M11.66M625.38M463.26M291.77M-24.83M-1.67B-22.14M197.58M202.31M296.81M266.92M265.43M62.48M45.15M-187.54M159.31M135.22M58.91M
Minority Interest316.62M370.38M338.62M70.04M73M78M67M60M41.15M264.11M264.11M273.55M274.63M275.44M660.56M663.44M654.31M654.14M700M000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Legacy liability runoff volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q3)

Equity Erosion Amid Structural Transition

As reported in recent financial statements, Ambac's equity base has contracted significantly from $1.5 billion in 2024Q3 to $843.4 million by 2025Q3, signaling that the ongoing transition toward a specialty insurance model is consuming capital faster than the legacy runoff can replenish it.

The sharp decline in shareholder equity suggests that the company is struggling to maintain its capital buffer while simultaneously funding the growth of its MGA and specialty P&C segments. Investors should monitor whether this trajectory indicates a permanent impairment of book value or merely a temporary phase of aggressive investment in new distribution channels.

Reserve Volatility Reflects Legacy Exposure

Based on quarterly data, claims and loss reserves have remained a persistent drag on the balance sheet, with $29.0 million in payments recorded in 2025Q3, illustrating the unpredictable nature of the legacy financial guarantee portfolio that continues to dominate the company's liability profile.

The fluctuation in loss reserves suggests that the company remains highly susceptible to adverse developments in its legacy RMBS and municipal bond exposures. This volatility complicates the assessment of the underlying underwriting performance of the newer Everspan segment, as legacy claims continue to obscure the true economic health of the firm.

Capital Adequacy Under Regulatory Pressure

According to recent SEC filings, the company's total assets dropped from $9.3 billion in 2024Q3 to $2.1 billion in 2025Q3, a massive shift that warrants further investigation into the regulatory constraints imposed by the Wisconsin OCI on capital upstreaming from the legacy subsidiary.

The dramatic reduction in total assets appears to reflect the aggressive de-risking of the legacy balance sheet, yet the concurrent decline in equity suggests that this process is not yet accretive to shareholders. The company's ability to deploy capital into its growth segments remains heavily dependent on the successful resolution of these legacy liabilities.

Legacy Liabilities Obscure Growth Potential

As indicated by the persistent negative ROE of -9.5% in 2025Q3, the company's balance sheet remains fundamentally tethered to legacy risks, which may be masking the potential value of the Cirrata MGA platform as noted in recent institutional research.

The primary risk to the balance sheet is not the growth of the new segments, but the potential for legacy litigation and claims to exceed current reserve estimates. Investors should be cautious, as the current valuation may be overly optimistic regarding the speed at which the company can fully ring-fence its historical liabilities.

OSG — Frequently Asked Questions

Quick answers to the most common questions about buying OSG stock.

What are the total assets of Octave Specialty Group, Inc. (OSG)?

As of 2025, Octave Specialty Group, Inc. (OSG) had total assets of $2.22B including $1.08B in current assets.

How much debt does Octave Specialty Group, Inc. (OSG) have?

Octave Specialty Group, Inc. (OSG) carries total debt of $117.6M, offset by $337.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Octave Specialty Group, Inc.?

Octave Specialty Group, Inc. (OSG) has total shareholders' equity (book value) of $715.8M ($23.02 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Octave Specialty Group, Inc.'s current ratio and liquidity?

Octave Specialty Group, Inc. (OSG) reported a current ratio of 1.19x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.